22 February 2018
News and Views
Links and Services
February's issue of Gut reports on the preventions of daily soluble aspirin of colorectal adenoma recurrence.
Aspirin inhibits colorectal carcinogenesis. In a randomised double-blind placebo-controlled trial
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors